A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc.
Astellas Pharma Inc
Merck Sharp & Dohme LLC
Mayo Clinic
Xencor, Inc.
NuCana plc
OncoC4, Inc.
RAPT Therapeutics, Inc.
Carisma Therapeutics Inc
Vincerx Pharma, Inc.
Salubris Biotherapeutics Inc
Atreca, Inc.
Fate Therapeutics
Xencor, Inc.
Gossamer Bio Inc.
Silverback Therapeutics
Incyte Corporation
MultiVir, Inc.